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The formation of new blood vessels occurs by sprouting from previously existing microvasculature. The 
process involved directed migration of the vascular endothelial cells towards chemical signals released from 
the target tissue. We have used the Boyden chemotaxis chamber method to identify chemotactic signals for 
fetal bovine vascular endothelial cells. Human placenta organ cultures produce a high-M, chemoattractant 
for the endothelial cells from which a low-M, factor can be liberated with trichloroacetic acid treatment 
and ethanol extraction. This activity was isolated from extracts of human placenta using Sephadex LH-20, 
Amberlite XAD-2, and silica gel thin-layer chromatography. The M, of the factor is less than 400, it is lipo- 
philic and resistant o proteolytic enzymes. The factor induces chemotactic migration of both aortic endo- 
thelial cells and capillary endothelial cells from the retina, but has no effect on fibroblasts or leukocytes 
suggesting aspecific function of the compound for the vascular endothehal cells. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
In new blood vessel formation, or angiogenesis, 
the vascular endothelial cells at the tips of the 
neovascular sprouts actively migrate towards the 
inciting stimulus [ 1,4]. It was previously suggested 
by Sepp& et al. [5,6] that chemotaxis assays may be 
used as an in vitro assay to elucidate angiogenic 
substances that act directly on the vascular en- 
dothelial cells. In the in vivo angiogenesis assays 
[7-l l] it is not possible to differentiate between in- 
direct and direct action of a compound on the final 
target, the vascular endothelium. We have now 
used the Boyden chamber chemotaxis assay to 
characterize a chemotactic activity for vascular en- 
dothelial cells present in organ culture medium and 
extracts of human placenta, a tissue which is highly 
vascular and is available alive in large amounts for 
the isolation procedure. 
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Chemotaxis assays were performed using the 
multiwell version of the modified Boyden chamber 
(Neuroprobe, Bethesda, MD) with 8 pm pore size 
polycarbonate filters (Nucleopore, Pleasanton, 
CA) which were coated with gelatin and fibronec- 
tin as described [6,12]. Briefly, the lower plate of 
the chamber consists of 48 wells, each of which has 
a surface area of approx. 8 mm2 and holds 25 yl of 
chemoattractant. The upper plate consists of 48 
holes which correspond to the wells on the bottom 
plate. Between the upper and lower plates are in- 
terposed a gelatin- and fibronectin-coated polycar- 
bonate filter of 10 pm thickness with 8-pm pores 
and a silicon gasket o make a tight seal. The upper 
wells hold up to 50~1 of cell suspension. Cell 
suspensions were incubated in the chemotaxis 
chambers for 4 h at 37°C in a humidified at- 
mosphere of 95% sir/5% Cot. After incubation, 
the filter was removed from the chamber, and 
stained using Diff-Quick. The filter with stained 
cells was placed on a microscope slide with the 
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lower surface (containing the migrated cells) facing 
the slide. Cells which did not migrate through the 
filter were wiped off the upper surface with a cot- 
ton swab. Migrated cells on the lower surface of 
the filter were counted in 15 consecutive fields 
along the diameter of each well at a magnification 
of 400 x . The counted area corresponds to ap- 
prox. 1 mm*, and the results are expressed as 
number of cells per mm* on the lower surface of 
the filter. Checkerboard assays were performed us- 
ing the single well chamber versions (Neuroprobe, 
Bethesda, MD). Assays for leukocyte chemotaxis 
were performed using 5 pm pore size filters which 
were without PVP-coating, as described [13]. 
Positive controls were retinal extract for endothe- 
lial cells, platelet derived growth factor (a kind gift 
from Dr C.-H. Heldin, University of Uppsala, 
Sweden) for fibroblasts, and formylmethionylleu- 
cylphenylalanine (Sigma) for leukocytes. Samples 
were diluted into DMEM containing bovine serum 
albumin at 1 mg/ml (= DMEM-BSA). 
2.2. Cell cultures 
Fetal bovine aortic endothelial cells [14] and 
bovine retinal capillary endothelial cells [ 151 were 
isolated and cultured as described. The identity of 
the cells was ascertained with immunohistochem- 
ical staining for factor VIII antigen [16]. Con- 
fluent cultures were used for assays in passages 
4-16 of the aortic and passage 4 of the capillary 
endothelial cells. The human skin fibroblasts were 
a kind gift from Dr Leena Hlmalainen, Dept of 
Medical Biochemistry, University of Oulu, and 
cells from 3 different cultures were used. Leuko- 
cytes were produced by injecting thioglycollate in- 
traperitoneally and harvesting on the first day after 
injection [17]; 50-65% of the cells were neutro- 
phils. 
3. RESULTS AND DISCUSSION 
3.1. Live placental slices release a high-M, 
endothelial cell chemoattractant 
Tissue culture medium conditioned by pieces of 
human placenta was found to contain chemoat- 
tractant activity towards vascular endothelial cells. 
A gel filtration on Sephadex G-200 of this condi- 
tioned medium is depicted in fig.1, and shows a 
peak of activity eluting at volumes corresponding 
SEPHACRYL S-ZOO 
Fig. 1. Sephacryl S-200 chromatography. Gel filtration 
of serum-free tissue culture medium from organ cultures 
of human placental slices on Sephacryl S-200 
equilibrated with 0.3 M NaCl. Molecular mass 
standards were catalase (232 kDa), serum albumin 
(67 kDa), chymotrypsinogen (25 kDa). The V, was 
determined using Blue Dextran. 
to molecular masses of 50-100 kDa. Similar high- 
MI attractants have been described previously from 
cultures of murine sarcoma [a], human men- 
ingioma [18], 3T3 adipocytes [19], and in tissue 
fluid from angiogenesis reaction in the cornea [20]. 
3.2. Trichloroacetic acid precipitation and ethanol 
extraction reveals a low-M, chemoattractant 
Precipitation of the proteins of the placental 
conditioned medium with trichloroacetic acid leads 
to precipitation of the chemoattractant activity. 
The activity was extractable into ethanol. Pretreat- 
ment with trichloroacetic acid seems to be a prere- 
quisite for extractability of the activity in ethanol, 
possibly through denaturation of carrier protein, 
since in previous work with endothelial cell attrac- 
tants from cultures of murine sarcoma [6] and 
human meningioma [ 181 no activity was found in 
ethanol extracts of lyophilized conditioned media. 
A gel filtration of the placental extract in ethanol 
on Sephadex LH-20 revealed a peak of activity in 
the range of 150-400 Da (fig.2). 
3.3. Extraction and purification of the low-M, 
chemoattractant 
To prepare larger amounts of the chemoattrac- 
tant human placentas were minced and treated 
with trichloroacetic acid and subsequently ex- 
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Fig.2. Sephadex LH-20 chromatography. Gel filtration 
of an ethanol extract of a trichloroacetic acid precipitate 
of tissue culture medium from organ cultures of human 
placental slices on a Sephadex LH-20 equilibrated with 
96% ethanol. Molecular mass standards were triethylene 
glycol (150 Da), and polyethylene glycols of 400 Da, 
1000 Da, and 20000 Da. 
tracted with ethanol. The extract was then purified 
on Sephadex LH-20. The peak of activity from the 
LH-20 was diluted with water and adsorbed on an 
Amberlite XAD-2 resin. The activity was eluted 
with a gradient of increasing concentration of 
ethanol (fig.3). The peak fraction was used for fur- 
ther analysis. 
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Fig.3. Amberlite XAD-2 chromatography. The peak 
fractions from the Sephadex LH-20 chromatography 
were mixed into 10 vols of 25 mM Na-acetate buffer, 
pH 4.6. The diluted activity was applied to Amberlite 
XAD-2 resin (Sigma), washed with buffer. The resin was 
developed with a linear gradient of ethanol in water. 
The dry weight of the material in the placental 
extract was 30 g, the weight of the LH-20 material 
was approx. 1 g, and the dry weight of the XAD-2 
peak was approx. 10 mg. The yield cannot be 
calculated because of the presence of inhibitors, 
which does not allow for estimation of the concen- 
trations inducing half maximal responses. 
3.4. Analysis of the purity of the chemoattractant 
on TLC 
A sample of the peak fraction from the XAD-2 
chromatography was analyzed in silica gel TLC 
(fig.4). The activity migrated with an Rf of 0.35, 
but no corresponding spot could be visualized by 
iodine vapor or charring with sulfuric acid. The 
major impurity present was phosphatidylcholine 
migrating at an Rf of 0.72. The chemotactic activi- 
ty was rendered labile after the TLC. 
3.5. Characterization of the chemical properties 
of the chemoattractant 
To analyze whether a peptide moiety is responsi- 
ble for the chemoattractant activity, the effect of 
several proteolytic enzymes on the activity was 
studied. None of the enzymes totally abolished the 
SILICA GEL TLC 
Fig.4. Thin-layer chromatography on silica gel. 20-~1 
samples were spotted on silica gel 60 TLC plates 
(Merck), and eluted with chloroform : methanol :water 
(65 : 35 : 6). Chromatograms were dried and split into two 
halves. The first half was developed with iodine vapor 
and HzS04, and the second half was cut into 1 cm 
pieces, each of which was eluted with 0.2 ml methanol. 
The methanol was evaporated, the residue taken up into 
0.005 ml ethanol, and diluted with DMEM-BSA for 
chemotaxis assay. 
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activity in 24 h at 37”C, suggesting that no peptide 
bond susceptible to these enzymes is involved in 
the chemotactic property of this compound. The 
activity was resistant to boiling at acidic and 
neutral pH values, but some loss of activity took 
place at pH 10.7. Mild oxidation with periodate 
only led to a slight diminution of the activity, sug- 
gesting that a carbohydrate moiety essential for the 
activity is not present. Because of previous reports 
of the effect of copper ions on the motility of 
vascular endothelial cells [21], the effect of a 
chelating resin, Chelex 100, on the activity was 
tested. Treatment of the activity with Chelex did 
not reduce the activity suggesting that no copper 
ions essential for the activity were present in the 
preparation. Addition of copper to the attractant 
did not have any effect on its activity either. 
Acetylation of the XAD peak fraction with acetic 
anhydride leads to an essential reduction of the 
chemotactic activity suggesting the presence of 
hydroxyl group(s) essential for the activity. The ac- 
tive fractions of the purest samples, the fraction 
from the TLC, had no absorbance at 254 or 
340 nm. It is possible that in spite of the high 
biological activity of the sample, the molar concen- 
tration of the active compound is too low for 
detection of absorbance. Chemoattractants are 
known to be active at very low concentrations, 
e.g., the leukocyte attractant formylmethionylleu- 
cylphenylalanine is active at lo-l2 M [22]. 
On the basis of the present data it is not possible 
to deduce the structure of the compound. We now 
know that the attractant is a small lipophilic 
molecule (soluble in chloroform) with an acetic 
anhydride acetylatable hydroxyl group essential 
for the activity. The activity is not leukotriene B4, 
prostaglandin El or Ez, or FMLP, as these have 
previously been tested (SeppP, unpublished) and it 
is not the platelet activating factor, which we 
found inactive towards endothelial cells in our 
assays (not shown). For further biochemical 
analysis and identification of the compound larger 
amounts of pure material are required. To achieve 
this a considerable scaling up of the isolation is 
needed. 
3.6. Characterization of the biological properties 
of the chemoattractant 
3.6.1. Analysis of the chemotactrc vs 
chemokinetic property of the compound 
The migratory responses of vascular endothelial 
cells to various concentration gradients between 
the upper and lower compartment in the Boyden 
chamber were tested to find out whether the 
responses were due to increased random migra- 
tion, or due to directed migration of the cells 
towards a higher concentration of the compound 
on the other side of the filter (table 1). The 
responses to ‘negative gradients’ (first line of the 
table) are less than the responses in the control 
(i.e., in the absence of attractant). The responses 
to increasing concentrations in the absence of a 
gradient (diagonal of the table) are equal to the 
control, showing that the attractant does not act 
through increasing the random motility of the 
cells, but acts by inducing increased migration of 
cells in ‘positive gradients’ towards increasing con- 
centrations of the placental factor (columns of the 
table). 
3.6.2. Cell specificity 
The fetal bovine aortic endothelial cells were 
used as ‘indicator cells’ in the isolation of the 
chemoattractant. As angiogenesis is a phenom- 
enon of the microvasculature, we tested whether 
capillary endothelial cells would be responsive to 
the factor. As depicted in fig.5 the bovine retinal 
capillary cells respond at a concentration nearly 2 
orders of magnitude smaller than that giving a 
maximal response with the aortic endothelial cells, 
suggesting that the capillary cells are even more 
sensitive to the compound than the aortic cells. 
The chemoattractant is not active for human 
fibroblasts (fig.5) or rat leukocytes (not shown) at 
Table 1 
Migratory responses of vascular endothelial cells to 
varied concentration gradients of placental factor 
Concentration Concentration above filter 
below filter 
0 lx 10 x 
0 351* 5 308 + 15 199 z!z 15 
lx 760 z!z 28 438 f 65 279 f 28 
10 x 689 + 42 631 f 39 339 f 30 
Results expressed as numbers of cells per mm2 on the 
lower surface of the filter. The numbers give the mean 
from triplicates f SE 
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Fig.5. A comparison of chemotactic responses of fetal 
bovine aortic endothelial cells (= FBAE), human 
fibrobl~ts, and bovine retinaI capillary endotheli~ cells 
(= BRCE) to the chemoattractant from placenta. 
Platelet-derived growth factor (= PDGF) was used as a 
positive control for the fibroblasts [ 121, 
the concentrations tudied, suggesting that the ac- 
tivity is specific for the endothehal cells. Whether 
this compound is related to the low-M, angiogene- 
sis factors that have been described previously 
[23-261 cannot be decided on the basis of the 
available information. Our preliminary results 
from angiogenesis assays using the chick chorio- 
nallantois membrane model would, however, sug- 
gest that the compound is angiogenic. 
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